Biogen Overview
Biogen Target Price
Analysts' 12-month price predictions for BIIB.
Get informed when a big investor buys or sells
+ FollowShare Price
$191.95
Average Target Price
$221.40
15.3% upside
15.3% upside15 analysts in the last 4 months
High: $260 | Low: $157
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-08 | Morgan StanleyTerence Flynn | $222 | 15.7% upside |  |
| 2026-07-07 | RBC Capital | $242 | 26.1% upside | |
| 2026-07-06 | HSBCMorten Herholdt | $157 |  18.2% downside | |
| 2026-06-18 | Morgan Stanley | $224 | 16.7% upside | |
| 2026-06-15 | Mizuho SecuritiesSalim Syed | $221 | 15.1% upside | |
| 2026-06-08 | Needham | $255 | 32.8% upside | |
| 2026-05-27 | RBC CapitalBrian Abrahams | $227 | 18.3% upside | |
| 2026-05-15 | Piper Sandler | $225 | 17.2% upside | |
| 2026-04-30 | Guggenheim | $260 | 35.5% upside | |
| 2026-04-30 | Wedbush | $196 | 2.1% upside | |
| 2026-04-30 | RBC CapitalBrian Abrahams | $222 | 15.7% upside | |
| 2026-04-30 | Morgan Stanley | $206 | 7.3% upside | |
| 2026-04-20 | Wells FargoMohit Bansal | $250 | 30.2% upside | |
| 2026-04-14 | Piper Sandler | $214 | 11.5% upside | |
| 2026-04-10 | Morgan Stanley | $200 | 4.2% upside | |
| 2026-02-19 | BarclaysEmily Field | $185 | 3.6% downside | |
| 2026-02-11 | Mizuho Securities | $236 | 22.9% upside | |
| 2026-02-10 | WedbushLaura Chico | $187 | 2.6% downside | |
| 2026-02-09 | Wolfe Research | $231 | 20.3% upside | |
| 2026-02-09 | Piper Sandler | $177 | 7.8% downside | |
| 2026-02-09 | H.C. WainwrightAndrew Fein | $228 | 18.8% upside | |
| 2026-02-09 | Tudor PickeringWilliam Pickering | $201 | 4.7% upside | |
| 2026-02-09 | GuggenheimYatin Suneja | $246 | 28.2% upside | |
| 2026-02-09 | Canaccord Genuity | $230 | 19.8% upside | |
| 2026-02-09 | Truist FinancialDanielle Brill | $193 | 0.5% upside | |
| 2026-02-09 | Wolfe Research | $215 | 12% upside | |
| 2026-02-09 | RBC Capital | $233 | 21.4% upside | |
| 2026-02-08 | Morgan StanleyTerence Flynn | $190 | 1% downside | |
| 2026-02-08 | Wells Fargo | $200 | 4.2% upside | |
| 2026-02-06 | BMO CapitalEvan Seigerman | $196 | 2.1% upside | |
| 2026-02-03 | Bernstein | $191 | 0.5% downside | |
| 2026-01-30 | OppenheimerJay Olson | $225 | 17.2% upside | |
| 2026-01-08 | Truist Financial | $190 | 1% downside | |
| 2026-01-08 | Goldman SachsSalveen Richter | $225 | 17.2% upside | |
| 2026-01-06 | UBS | $185 | 3.6% downside | |
| 2025-12-12 | Morgan StanleyTerence Flynn | $156 | 18.7% downside | |
| 2025-12-10 | HSBC | $143 | 25.5% downside | |
| 2025-11-21 | Piper Sandler | $157 | 18.2% downside | |
| 2025-11-03 | Bernstein | $157 | 18.2% downside | |
| 2025-11-03 | Tudor PickeringWilliam Pickering | $157 | 18.2% downside | |
| 2025-10-31 | Robert W. Baird | $250 | 30.2% upside | |
| 2025-10-10 | Morgan Stanley | $149 | 22.4% downside | |
| 2025-09-25 | JefferiesAndrew Tsai | $190 | 1% downside | |
| 2025-06-25 | RBC CapitalBrian Abrahams | $213 | 11% upside | |
| 2025-05-05 | H.C. WainwrightAndrew Fein | $187 | 2.6% downside | |
| 2025-05-02 | OppenheimerJay Olson | $205 | 6.8% upside | |
| 2025-04-28 | HSBC | $118 | 38.5% downside | |
| 2025-02-13 | Canaccord GenuitySumant Kulkarni | $265 | 38.1% upside | |
| 2025-02-12 | Wells FargoMohit Bansal | $165 | 14% downside | |
| 2025-02-12 | NeedhamAmi Fadia | $270 | 40.7% upside | |